セッション詳細
[WS(O)22]New molecular and cellular mechanisms in cancer immunology
2024年12月4日(水) 15:10 〜 16:25
Room H
Organizers: Yoshihiro Hayakawa (Toyama University), Naoko Ohtani (Osaka Metropolitan Universit)
[WS22-01-O/P]Satb1 maintains the functionality of regulatory and cytotoxic T cells during tumor responses
○Wooseok Seo1,2, Chengcheng Zou2, Kanako Shimizu2, Ruka Setoguchi3, Kiyokazu Kakugawa2, Krutula Nair2, Haruhiko Koseki2, Terumi Kohwi-Shigematsu4, Shohei Hori3, Shin-ichiro Fujii2, Hiroyoshi Nishikawa1, Ichiro Taniuchi2 (1.Nagoya University / Dep. of Immunology, 2.RIKEN, 3.University of Tokyo, 4.University of California)
[WS22-08-O/P]T cell exhaustion steps according to mitochondrial status and the analysis of their glycolytic function
○Koji Kitaoka1, Yasuharu Haku1, Tomonori Yaguchi1,2, Tasuku Honjo1, Kenji Chamoto1,2 (1.Center for Cancer Immunotherapy and Immunobiology Graduate School of Medicine Kyoto University, 2.Department of Immuno-Oncology PDT, Graduate School of Medicine Kyoto University)
[WS22-10-O/P]A novel pro-tumourigenic mechanism of Ex-Regs in cancer
○Qiao Gou1, Hiroyuki Takaba1, Daizo Koinuma2, Kohei Miyazono2,3, Hiroshi Takayanagi1 (1.Department of Immunology, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, 2.Department of Molecular Pathology, Graduate School of Medicine, The University of Tokyo, 3.Department of Applied Pathology, Graduate School of Medicine, The University of Tokyo)
[WS22-13-O/P]Establishment of monoclonal antibodies derived from tumor-infiltrating B cells for cancer therapeutic application.
○Tsubasa Kobayashi1, Toshihiro Suzuki2, Tetsuya Nakatsura2, Daisuke Kitamura1 (1.Research Institute for Biomedical Sciences, Tokyo University of Science, 2.Division of Cancer Immunotherapy, EPOC, National Cancer Center)
[WS22-15-O/P]Impacts of tumor-derived DCs on the thymus function
○Yangsong Wang, Ichita HASEGAWA, Yukihiro ENDO, Ryo NASU, Motoko KIMURA (Chiba University)
[WS22-24-O/P]Deletion of the endoribonuclease Regnase-1 unleashes NK cell anti-tumor activity via OCT2-dependent transcription of Ifng
○Yasuharu Nagahama1,2, Shizuo Akira1,3,4 (1.Laboratory of Host Defense, WPI Immunology Frontier Research Center, Osaka University, 2.Host Defense Laboratory, Immunology Unit, Osaka Research Center for Drug Discovery, Otsuka Pharmaceutical Co., Ltd., 3.Center for Advanced Modalities and Drug Delivery System, Osaka University, 4.Department of Host Defense, Research Institute for Microbial Diseases, Osaka University)
[WS22-27-O/P]Fibroblastic reticular cell-derived CXCL12 controls immunosuppression in tumor-draining lymph nodes
○Yasuhiro Kanda1, Madoka Ozawa1, Takashi Nagasawa2, Tomoya Katakai1 (1.Department of Immunology, Niigata University Graduate School of Medical and Dental Sciences, 2.Laboratory of Stem Cell Biology & Developmental Immunology, Graduate School of Frontier Biosciences, Osaka University)
[WS22-28-O/P]LPS promotes mast cells induced fibrosis in cancer tissue by increasing CXCL8 and CCL19 expression
○Xiangmei Zhang1, Jidong Zhao2, Baoen Shan1 (1.Hebei Provincial Cancer Institute, Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China, 2.Department of Thoracic Surgery, Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China)